Genmab | GEN - Kreditur Perdagangan





Kreditur Perdagangan Perubahan Tanggal
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Almirall EUR 235.53M 22.52M 2026-06
Amarin USD 18.8M 29.36M 2026-06
Amgen USD 2.86B 16.65B 2026-06
argenx SE USD 719M 164.73M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Bayer EUR 6.59B 496M 2026-03
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Demant DKK 923M 41M 2025-12
Exelixis USD 24.15M 5.47M 2026-03
Fresenius Medical Care EUR 890.43M 54.88M 2026-03
Genmab DKK 116M 110M 2026-06
GlaxoSmithKline GBP 14.34B 7M 2026-06
GN Store Nord DKK 1.01B 486M 2026-03
GRIFOLS EUR 1B 160M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
Insmed USD 74.55M 1.18M 2026-06
Lakefront Biotherapeutics EUR 95.77M 8.88M 2026-03
Lonza CHF 471M 3M 2024-12
Merck EUR 2.13B 19M 2026-03
Novartis USD 4.26B 64M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
UCB EUR 4.04B 755M 2025-12